Clinical Trial

PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a Phase II treatment study analyzing the role of preoperative chemotherapy, preoperative laparoscopic HIPEC, and gastrectomy with CRS/HIPEC in gastric adenocarcinoma patients with cytology-positive only carcinomatosis, radiologically-occult carcinomatosis, or radiology apparent peritoneal-surface only metastatic disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-11.
Trial Details
NCT Number NCT07178808
Lead Sponsor Banner Health
Conditions Gastric Adenocarcinoma
Enrollment 30 participants
Start Date 2021-04-16
Primary Completion 2031-02-22 (estimated)
Study Completion 2031-02-22 (estimated)
Updated on ClinicalTrials.gov 2026-05-01